Page 2873 - Markets News

MARKET WRAP: Sensex rises 224 pts, Nifty ends at 11,537; RIL, pharma cos up

Among sectoral indices, Nifty Pharma index settled 2.7 per cent higher led by Aurobindo Pharma and Biocon.

Sun Pharma, Glenmark Pharma, Hikal hit 52-week highs; Aurobindo surges 8%

Granules India, Hikal, Pfizer, Lincoln Pharmaceuticals, Astrazeneca Pharma India and Aarti Drugs were up between 4% and 7%.

Wipro gains for seventh straight trading day; stock up 16% in one month

Wipro has outperformed the market by surging 16% in past one month, as compared to 1% rise in the S&P BSE Sensex, trading close to its 52-week high of Rs 335 touched on January 16, 2018.

NCDEX plans for commodity derivatives to address NPAs, volatile agri prices

NCDEX will propose to the regulator to allow options in more agri commodities

Rupee breaches 72 to the dollar to hit new low, no RBI intervention seen

The rupee fell to a record low of 72.11 to the dollar at one point, with strong bids for dollars coming after 70 was hit, traders said

Paper stocks rally; West Coast, Star Paper, Seshasayee Paper up over 7%

Orient Paper & Industries, Nath Pulp & Paper Mills and Ballarpur Industries were up 6% each, while JK Paper and International Paper APPM have locked in upper circuit of 5% on the BSE.

Adani Enterprises trades ex-date for spin off; rebounds 15% from day's low

The stock moved higher by 7% to Rs 161, bouncing back 15% from its early morning low of Rs 140 on the BSE on back of heavy volumes.

Aurobindo Pharma gains 5% on acquisition of Sandoz's US business

The stock rallied 5% to Rs 732 on Thursday, extending its Wednesday's 2% gain on the BSE, after the company announced the acquisition of Sandoz's generic business in the US for $900 million.

Nifty Media index tanks 5%; Zee Entertainment, Sun TV hits 52-week lows

Zee Entertainment Enterprises plunged 9.5% to Rs 436 in early morning trade on the NSE.

Why a start-stop approach to SIPs could hurt your crucial financial goals

You will also lose out on the chance to buy fund units at lower prices and boost returns

Troubled times to last a while longer for emerging markets, say hedge funds

To blunt the blow of the trade war, Beijing recently switched its economic priorities and is ready to deploy infrastructure spending again

Nifty outlook and top trading calls by Prabhudas Lilladher for today

Nifty outlook and few trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher

With RBI's policy rate hike, housing finance firms to face tough time

Housing finance companies (HFCs) are expected to find this difficult, given stiff competition in their segment

Market regulator Sebi mulls diluting controversial FPI KYC norms: Sources

April circular likely to exempt PIOs, publicly pooled funds

Today's picks: From BPCL to Zee, hot stocks to watch on Thursday

For Zee Entertainment, keep a stop at Rs 485 and go short. Add to the position between Rs 474 and Rs 475. Book profits at Rs 472

Angel Broking files offer document with Sebi for IPO to raise Rs 6 billion

Sources say the offer will value Angel Broking around Rs 25 billion

Nifty index weights skew returns

The paradox of a bull run which hasn't rewarded investors holding portfolios similar to the Nifty is due to the quirk of index construction

Not the right time for listing, looking for better value, says ONGC Videsh

The government had last month asked ONGC to list its overseas investment arm OVL on stock exchanges and transfer proceeds to it in the form of a special dividend

New motor norms trigger for ICICI Lombard, will gain most among insurers

Expected benefits from the revised motor third-party insurance policy have been the reason for the upward move

Improved US prospects, domestic outlook to drive Sun Pharma's earnings

The key near-term trigger is the company's specialty pipeline